Solving Scalability in Clinical Trials Date Published: Aug 27, 2020 Article Clinical trial data must be maintained in a separate, compartmentalized database, but this poses a problem to those managing hundreds of studies at once. This Applied Clinical Trials article explores scalability strategies amidst the recent COVID-19 pandemic, and what this means for the future of clinical research. Popular countermeasures addressing COVID-related challenges include reimagining how site monitoring is conducted and enabling decentralized trials with technology. Experts also weigh in on the benefits of transitioning from on-site trials to at-home assessments, how to keep regulators’ support, and the growing importance of digital health. Find out essential next steps to prepare for the industry’s new norm in this PharmaVOICE article. Download Now Share: LinkedInTweet Recommended Resources Article Optimal COA Measurement Strategy in Modern Oncology Trials The inclusion of patient-reported outcomes (PRO) data in oncology medication labeling in the U.S. has been comparatively limited. Recent FDA... Read Now Article Innovations in Clinical Neuroscience: Articles on Pediatric and Orphan Disease Clinical Research Dr. Joan Busner, Signant’s Clinical Vice President and in-house expert on pediatric and orphan disease clinical trials, recently co-authored three... Download Now Article Cariprazine Found to be Effective Adjunctive Treatment for Major Depressive Disorder Treating major depressive disorder can be challenging since many patients do not respond to initial antidepressant treatment, leading to continued... Read the Article